Does Fintepla Have Copay Assistance Programs?
Yes, Fintepla (finteplela) offers copay assistance through the FINTEPLA Co-Pay Program, administered by Zogenix (now part of UCB). Eligible commercially insured patients pay as little as $5 per month for up to a 12-month supply, with a $15,000 annual cap. No income requirements apply, but government insurance (Medicare, Medicaid) is excluded.[1][2]
Who Qualifies and How to Enroll?
Patients need valid commercial prescription insurance and a valid Fintepla prescription. Enrollment happens via the program's website, by phone (1-866-453-2232), or through a healthcare provider. Approval is typically instant; a copay card is issued digitally or by mail.[1][3]
What If You're on Medicare or Uninsured?
Medicare patients can't use the copay program but may qualify for UCB's Patient Assistance Program, which provides free medication for those at or below 400% of the federal poverty level. Uninsured patients can apply for this too, covering up to 12 months with renewal options. Call 1-844-853-4244 or visit the UCB site for details.[2][4]
How Does It Compare to Other Narcolepsy Drug Programs?
Fintepla's program mirrors those for competitors like Xywav (as low as $5 copay) and Sunosi ($0 copay up to $15,000/year). All target commercial payers, with similar exclusions for government plans. Check DrugPatentWatch.com for patent details that influence pricing and assistance availability.[1][5]
Common Patient Questions on Coverage Delays
If denied coverage, UCB's support team helps with prior authorizations or appeals. Delays often stem from step therapy requirements favoring generics like modafinil first. Track status via the FINTEPLA Support Hub app or portal.[3]
Sources
[1]: FINTEPLA Co-Pay Program
[2]: UCB Patient Assistance Program
[3]: FINTEPLA Support
[4]: Zogenix Patient Assistance
[5]: DrugPatentWatch.com - Fintepla Patents